The role of hypoxia-inducible factors in cancer

被引:145
作者
Maynard, M. A. [1 ]
Ohh, M. [1 ]
机构
[1] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada
关键词
HIF; VHL; PI3K; MAPK; PHD;
D O I
10.1007/s00018-007-7082-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hypoxia-inducible factor (HIF) is a heterodimeric transcription factor that mediates the adaptive responses to hypoxia by effecting the transcription of numerous hypoxia-inducible genes. HIF is frequently overexpressed in solid tumors, and the transactivation of HIF targets in transformed cells provides a distinct survival advantage. Accordingly, the upregulation of HIF correlates with increased progression or aggressiveness of the cancer and poor prognosis. In addition to the induction of HIF by hypoxia, its expression is induced by the loss of tumor suppressors VHL, PTEN, TSC1/2, PML, and SDH, as well as by the increased activity of PI3K and/or MAPK signaling pathways, underscoring the significance of HIF in oncogenesis.
引用
收藏
页码:2170 / 2180
页数:11
相关论文
共 149 条
[41]   VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail [J].
Evans, Andrew J. ;
Russell, Ryan C. ;
Roche, Olga ;
Burry, T. Nadine ;
Fish, Jason E. ;
Chow, Vinca W. K. ;
Kim, William Y. ;
Saravanan, Arthy ;
Maynard, Mindy A. ;
Gervais, Michelle L. ;
Sufan, Roxana I. ;
Roberts, Andrew M. ;
Wilson, Leigh A. ;
Betten, Mark ;
Vandewalle, Cindy ;
Berx, Geert ;
Marsden, Philip A. ;
Irwin, Meredith S. ;
Teh, Bin T. ;
Jewett, Michael A. S. ;
Ohh, Michael .
MOLECULAR AND CELLULAR BIOLOGY, 2007, 27 (01) :157-169
[42]  
Felder CB, 1999, AAPS PHARMSCI, V1
[43]   Analysis of ARD1 function in hypoxia response using retroviral RNA interference [J].
Fisher, TS ;
Des Etages, S ;
Hayes, L ;
Crimin, K ;
Li, BY .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (18) :17749-17757
[44]   HRF, a putative basic helix-loop-helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor-1 alpha and developmentally expressed in blood vessels [J].
Flamme, I ;
Frohlich, T ;
vonReutern, M ;
Kappel, A ;
Damert, A ;
Risau, W .
MECHANISMS OF DEVELOPMENT, 1997, 63 (01) :51-60
[45]  
Folkman J, 1992, Semin Cancer Biol, V3, P65
[46]   SOMATIC MUTATIONS OF THE VON HIPPEL-LINDAU DISEASE TUMOR-SUPPRESSOR GENE IN NONFAMILIAL CLEAR-CELL RENAL-CARCINOMA [J].
FOSTER, K ;
PROWSE, A ;
VANDENBERG, A ;
FLEMING, S ;
HULSBEEK, MMF ;
CROSSEY, PA ;
RICHARDS, FM ;
CAIRNS, P ;
AFFARA, NA ;
FERGUSONSMITH, MA ;
BUYS, CHCM ;
MAHER, ER .
HUMAN MOLECULAR GENETICS, 1994, 3 (12) :2169-2173
[47]   Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1α [J].
Freedman, SJ ;
Sun, ZYJ ;
Poy, F ;
Kung, AL ;
Livingston, DM ;
Wagner, G ;
Eck, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (08) :5367-5372
[48]   Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells [J].
Fukuda, R ;
Hirota, K ;
Fan, F ;
Do Jung, Y ;
Ellis, LM ;
Semenza, GL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (41) :38205-38211
[49]   Hypoxia-inducible factor-1α-expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer [J].
Generali, Daniele ;
Berruti, Alfredo ;
Brizzi, Maria P. ;
Campo, Leticia ;
Bonardi, Simone ;
Wigfield, Simon ;
Bersiga, Alessandra ;
Allevi, Giovanni ;
Milani, Manuela ;
Aguggini, Sergio ;
Gandolfi, Valeria ;
Dogliotti, Luigi ;
Bottini, Alberto ;
Harris, Adrian L. ;
Fox, Stephen B. .
CLINICAL CANCER RESEARCH, 2006, 12 (15) :4562-4568
[50]   Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival [J].
Giatromanolaki, A ;
Koukourakis, MI ;
Sivridis, E ;
Turley, H ;
Talks, K ;
Pezzella, F ;
Gatter, KC ;
Harris, AL .
BRITISH JOURNAL OF CANCER, 2001, 85 (06) :881-890